Delivery Order SPE2DR25D2206-SPE2DR26F9LD5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $37,975.20 to AmerisourceBergen Drug Corp for the supply of Padcev 30 mg vials, a specialized pharmaceutical product. The contract, issued on December 2, 2025, with an ultimate completion date of December 23, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $18,421.92 delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Padcev 30 mg vials, a specialty pharmaceutical product used in oncology treatment. The order, which carries an ultimate completion date of January 29, 2026, was competitively awarded with no set-aside designation and features firm fixed-price terms. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $17,526.96 on December 4, 2025, for the supply of Padcev 30 mg vials, with a completion date of December 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, PA 19428. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,543.85 to AmerisourceBergen Drug Corp for Padcev 20 mg vials on November 4, 2025, with an ultimate completion date of November 26, 2025. This firm fixed-price delivery order is non-set-aside and competitively awarded, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,391.80 delivery order for Padcev 20 mg vials under a firm fixed-price contract with an ultimate completion date of August 11, 2025. This is a non-set-aside award, meaning it was competitively awarded without restrictions. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order valued at $14,783.60 to AmerisourceBergen Drug Corp for Padcev 20 mg vials, with a firm fixed price and an ultimate completion date of December 1, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,543.85 to AmerisourceBergen Drug Corp for the supply of Padcev 20 mg vials, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,658.40 for 30 mg vials of Padcev on December 15, 2025, with completion targeted for January 7, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,847.95 to AmerisourceBergen Drug Corp for the supply of Padcev 20 mg vials, with an ultimate completion date of September 16, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Padcev 20 mg vials, a chemotherapy medication used in cancer treatment. This competitively awarded, firm fixed-price delivery order has a ceiling value of $15,579.68 and is scheduled for completion by December 10, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9LD5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $53.5K to AmerisourceBergen Drug Corp for supply of Padcev 30 mg vials, a specialty pharmaceutical product. This non-set-aside, competitively awarded contract carries firm fixed pricing and is scheduled for completion by February 5, 2026. The award was issued on January 14, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), maintains a significant IDC with DLA valued at up to $999,999,999.00 through December 2031. These vehicles serve as comprehensive global pharmaceutical support mechanisms enabling the contractor to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and federal medical systems worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $53.5k | 1/13/26 |